BTCS
BTCS Inc. Common Stock
stock NASDAQ

*Seasoned finance executive brings more than 25 years of leadership experience across technology, digital infrastructure, software, fintech and emerging growth companies*
VANCOUVER, British Columbia, Sept. 29, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com/) \-- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) ("**Optimi**" or the "**Company**"), a commercial-stage manufacturer and clinical-stage developer of regulated psychedelic drug products, today announced the appointment of Melanie Pump to its Board of Directors (the "**Board**").
Ms. Pump is a seasoned finance executive with more than 25 years of experience across technology, digital infrastructure, software, fintech and emerging growth companies. She currently serves as Chief Financial Officer of Qu Data Centres.
*"We are pleased to welcome Melanie to Optimi's Board,"* said Dane Stevens, Optimi Chief Executive Officer and Co-Founder. *"Her extensive financial leadership experience across technology-driven and emerging growth companies, together with her public company board experience, will add valuable perspective as Optimi continues to execute on its strategic priorities and advance its position in the regulated psychedelic pharmaceutical market."*
Ms. Pump also currently serves on the Board of Directors of Mobio Technologies Inc. (TSXV: MBO) and previously served as a director of BTCS Inc. Her background combines senior financial leadership with public company governance experience across a range of technology-focused and growth-oriented businesses.
Read full release: https://finance.yahoo.com/healthcare/articles/optimi-health-appoints-melanie-pump-113000004.html

*Seasoned finance executive brings more than 25 years of leadership experience across technology, digital infrastructure, software, fintech and emerging growth companies*
VANCOUVER, British Columbia, Sept. 29, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com/) \-- Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) ("**Optimi**" or the "**Company**"), a commercial-stage manufacturer and clinical-stage developer of regulated psychedelic drug products, today announced the appointment of Melanie Pump to its Board of Directors (the "**Board**").
Ms. Pump is a seasoned finance executive with more than 25 years of experience across technology, digital infrastructure, software, fintech and emerging growth companies. She currently serves as Chief Financial Officer of Qu Data Centres.
*"We are pleased to welcome Melanie to Optimi's Board,"* said Dane Stevens, Optimi Chief Executive Officer and Co-Founder. *"Her extensive financial leadership experience across technology-driven and emerging growth companies, together with her public company board experience, will add valuable perspective as Optimi continues to execute on its strategic priorities and advance its position in the regulated psychedelic pharmaceutical market."*
Ms. Pump also currently serves on the Board of Directors of Mobio Technologies Inc. (TSXV: MBO) and previously served as a director of BTCS Inc. Her background combines senior financial leadership with public company governance experience across a range of technology-focused and growth-oriented businesses.
Read full release: https://finance.yahoo.com/healthcare/articles/optimi-health-appoints-melanie-pump-113000004.html